IQ-16 Soluble CD25
[IQ-16 CD25 soluble]
EPTIS factsheet 486382 | Last revision 2019-03-12 | URL: https://www.eptis.bam.de/pts486382 https://www.eptis.bam.de/pts486382
PT provider | ||||||||||||||||
PT provider | GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology) GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology) | |||||||||||||||
Based in | Spain | |||||||||||||||
Language(s) | English/Spanish | |||||||||||||||
Remarks | Soluble CD25 (soluble IL-2 receptor) is usually raised in serum in hemophagocytic lymphohistiocytosis (HLH) | |||||||||||||||
Keywords | ||||||||||||||||
Product groups |
Health care / medical devices
Human test material |
|||||||||||||||
Testing fields |
Biology
Medical analysis |
|||||||||||||||
Technical details | ||||||||||||||||
|
||||||||||||||||
Aims of the PT scheme | ||||||||||||||||
Target group of participants | ||||||||||||||||
Linked to specific legislation / standards | GECLID follows guidelines within ISO 17043 & ISO15328 | |||||||||||||||
Additional, subsidiary aims | ||||||||||||||||
Number of participants | 10 | |||||||||||||||
Accredited or otherwise reviewed by a 3rd party |
ISO 9001 certified |
|||||||||||||||
Operation is commissioned / requested by | ||||||||||||||||
Fees and frequency | ||||||||||||||||
Participation fee | 181.25 EU | |||||||||||||||
Regularly operated | Yes (Twice a year) | |||||||||||||||
Year of first operation | 2017 | |||||||||||||||
Contact details of the PT provider | ||||||||||||||||
Provider | Contact person | |||||||||||||||
GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Pº de Filipinos s/n 47007 Valladolid Spain Phone: +34 983 41 88 23 Ext.89673 Fax: Web: https://www.geclid.es https://www.geclid.es |
Dr. Carmen Martin
Phone: +34 686 247 331 Fax: Email: responsable@geclid.es responsable@geclid.es |